Recombinant Newcastle Disease Virus Encoding IL-12 and/or IL-2 as Potential Candidate for Hepatoma Carcinoma Therapy.

about

Reverse Genetics of Newcastle Disease Virus.Tune Up In Situ Autovaccination against Solid Tumors with Oncolytic Viruses.

P2860

Q40200048-3ECE5B57-DA05-41F1-8AE9-3A2FB0937504 Q55509278-3169A7E0-C66C-41F8-8EB3-131F8102A57A

P2860

Recombinant Newcastle Disease Virus Encoding IL-12 and/or IL-2 as Potential Candidate for Hepatoma Carcinoma Therapy.

Item

http://www.wikidata.org/entity/Q41456207

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

Recombinant Newcastle Disease ...... or Hepatoma Carcinoma Therapy.

@en

type

Item

label

Recombinant Newcastle Disease ...... or Hepatoma Carcinoma Therapy.

@en

prefLabel

Recombinant Newcastle Disease ...... or Hepatoma Carcinoma Therapy.

@en

P1476

Recombinant Newcastle Disease ...... or Hepatoma Carcinoma Therapy.

@en

P2093

Deshan Li

http://www.w3.org/2001/XMLSchema#string

Guiping Ren

http://www.w3.org/2001/XMLSchema#string

Guiyou Tian

http://www.w3.org/2001/XMLSchema#string

Jiechao Yin

http://www.w3.org/2001/XMLSchema#string

Jinjiao He

http://www.w3.org/2001/XMLSchema#string

Shuangqing Liu

http://www.w3.org/2001/XMLSchema#string

Tian Sun

http://www.w3.org/2001/XMLSchema#string

Xin Liu

http://www.w3.org/2001/XMLSchema#string

Xinyu Gao

http://www.w3.org/2001/XMLSchema#string

Xu Zhang

http://www.w3.org/2001/XMLSchema#string

P2860

Recombinant Newcastle disease virus as a vaccine vector for cancer therapy

Engineered newcastle disease virus as an improved oncolytic agent against hepatocellular carcinoma

IL-2 family cytokines: new insights into the complex roles of IL-2 as a broad regulator of T helper cell differentiation

Interleukin 12: still a promising candidate for tumor immunotherapy?

Multiple effects on peripheral hematology following administration of recombinant human interleukin 12 to nonhuman primates.

Localized oncolytic virotherapy overcomes systemic tumor resistance to immune checkpoint blockade immunotherapy.

Genetically engineered Newcastle disease virus expressing interleukin-2 and TNF-related apoptosis-inducing ligand for cancer therapy.

Requirement for Stat4 in interleukin-12-mediated responses of natural killer and T cells.

Targeted therapy for metastatic renal cell carcinoma.

Use of reverse genetics to enhance the oncolytic properties of Newcastle disease virus.

P304

NP83-94

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1177/1533034615601521

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2015-08-24T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

26303327

http://www.w3.org/2001/XMLSchema#string

Recombinant Newcastle Disease Virus Encoding IL-12 and/or IL-2 as Potential Candidate for Hepatoma Carcinoma Therapy.

about

P2860

P2860

Recombinant Newcastle Disease Virus Encoding IL-12 and/or IL-2 as Potential Candidate for Hepatoma Carcinoma Therapy.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698